Chongqing Yaoyou Pharmaceutical

Chongqing Yaoyou Pharmaceutical is a prominent Chinese pharmaceutical company and a key subsidiary of the Fosun Pharma group. Established in 1939, the company has developed a robust infrastructure for the research, development, and large-scale manufacturing of finished dosages and active pharmaceutical ingredients (APIs). It is a market leader in the hepatology segment, notably for its Ademetionine products used in treating liver diseases. Yaoyou Pharma maintains a strong international presence, with multiple production lines certified by the US FDA and EU GMP standards, enabling the export of generic and innovative medicines globally. The company's therapeutic focus extends across cardiovascular health, anti-infectives, oncology, and metabolic disorders.